
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
My wife and I are preparing to fly to Hong Kong and Singapore, where I will deliver some lectures. Naturally, we are trolling the Web to find information that will add pleasure and value to our journey.